Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.23.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Preferred Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Non-Controlling Interest
Beginning balance, common (in shares) at Mar. 31, 2022   97,163,701            
Beginning balance at Mar. 31, 2022 $ 516,215 $ 10 $ 100 $ (71) $ 745,661 $ (39,341) $ (191,788) $ 1,644
Beginning balance, preferred (in shares) at Mar. 31, 2022     100,000          
Beginning balance, treasury (in shares) at Mar. 31, 2022       758,125        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 14,958           14,922 36
Foreign currency translation (5,542)         (5,749)   207
Stock-based compensation expense 6,463       6,463      
Shares issued:                
Exercise of stock options (in shares)   380,176            
Exercise of stock options and warrants 296       296      
Issuance of restricted shares and vesting of restricted units (in shares)   7,763            
Shares for acquisition of Fyber (in shares)   1,205,982            
Shares for acquisition of Fyber 50,000       50,000      
Payment of withholding taxes related to the net share settlement of equity awards (4,357)       (4,357)      
Ending balance, common (in shares) at Jun. 30, 2022   98,757,622            
Ending balance at Jun. 30, 2022 $ 578,033 $ 10 $ 100 $ (71) 798,063 (45,090) (176,866) 1,887
Ending balance, preferred (in shares) at Jun. 30, 2022     100,000          
Ending balance, treasury (in shares) at Jun. 30, 2022       758,125        
Beginning balance, common (in shares) at Mar. 31, 2023 99,458,369 99,458,369            
Beginning balance at Mar. 31, 2023 $ 607,255 $ 10 $ 100 $ (71) 822,217 (41,945) (175,115) 2,059
Beginning balance, preferred (in shares) at Mar. 31, 2023 100,000   100,000          
Beginning balance, treasury (in shares) at Mar. 31, 2023 758,125     758,125        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) $ (8,399)           (8,179) (220)
Foreign currency translation (6,107)         (6,846)   739
Stock-based compensation expense $ 10,017       10,017      
Shares issued:                
Exercise of stock options (in shares) 548,310 378,507            
Exercise of stock options and warrants $ 731       731      
Issuance of restricted shares and vesting of restricted units (in shares)   449,781            
Acquisition of non-controlling interests in Fyber (3,751)       (1,173)     (2,578)
Payment of withholding taxes related to the net share settlement of equity awards $ (931)       (931)      
Ending balance, common (in shares) at Jun. 30, 2023 100,286,657 100,286,657            
Ending balance at Jun. 30, 2023 $ 598,815 $ 10 $ 100 $ (71) $ 830,861 $ (48,791) $ (183,294) $ 0
Ending balance, preferred (in shares) at Jun. 30, 2023 100,000   100,000          
Ending balance, treasury (in shares) at Jun. 30, 2023 758,125     758,125